Why the study?
Achieving optimal response to cardiac resynchronization therapy in patients with left ventricular non-compaction cardiomyopathy and complex clinical scenarios remains challenging.
Does atrioventricular node ablation improve left ventricular ejection fraction and clinical symptoms in a patient with LVNC and refractory atrial arrhythmias compromising CRT efficacy?
Case Report (n=1)
No
Does atrioventricular node ablation improve left ventricular ejection fraction and clinical symptoms in a patient with LVNC and refractory atrial arrhythmias compromising CRT efficacy?
Atrioventricular node ablation plays a pivotal role in ensuring effective CRT delivery and can result in significant echocardiographic improvement in complex LVNC patients with refractory atrial arrhythmias.
Left ventricular non-compaction cardiomyopathy (LVNC) is a rare myocardial disorder associated with heart failure and arrhythmias. Cardiac resynchronisation therapy (CRT) is an established treatment in patients with electrical dyssynchrony; however, achieving optimal response remains challenging in complex clinical scenarios. We report a 51-year-old male with LVNC, severe left ventricular dysfunction, morbid obesity, and recurrent atrial and ventricular arrhythmias. Despite initial improvement following CRT-D implan-tation, the patient developed progressive heart failure and recurrent ventricular tachycardia with high atrial arrhythmia burden, resulting in ineffective biventricular pacing. Following unsuccessful device optimisation strategies, a multidisciplinary decision was made to proceed with atrioventricular node ablation. This resulted in marked clinical and echocardiographic improvement, including recovery of left ventricular ejection fraction and symptomatic status. This case highlights the importance of ensuring adequate CRT delivery and demonstrates the pivot-al role of atrioventricular node ablation in patients with refractory atrial arrhythmias and suboptimal CRT response.
No takes yet. Share an insight, caveat, or question.
Farhangee et al. (2026) conducted a case report in Left ventricular non-compaction cardiomyopathy (LVNC) (n=1). Atrioventricular node ablation was evaluated on Clinical and echocardiographic improvement (left ventricular ejection fraction) at one-month follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: